1.15
price down icon5.74%   -0.07
after-market Handel nachbörslich: 1.15
loading
Schlusskurs vom Vortag:
$1.22
Offen:
$1.24
24-Stunden-Volumen:
555.36K
Relative Volume:
0.22
Marktkapitalisierung:
$19.56M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-39.14M
KGV:
-0.1926
EPS:
-5.97
Netto-Cashflow:
$-28.20M
1W Leistung:
-17.86%
1M Leistung:
-17.27%
6M Leistung:
-28.57%
1J Leistung:
-91.64%
1-Tages-Spanne:
Value
$1.10
$1.24
1-Wochen-Bereich:
Value
$1.10
$1.57
52-Wochen-Spanne:
Value
$0.65
$15.25

Citius Pharmaceuticals Inc Stock (CTXR) Company Profile

Name
Firmenname
Citius Pharmaceuticals Inc
Name
Telefon
(908) 967-6676
Name
Adresse
11 COMMERCE DRIVE, CRANFORD, NJ
Name
Mitarbeiter
23
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-07
Name
Neueste SEC-Einreichungen
Name
CTXR's Discussions on Twitter

Vergleichen Sie CTXR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CTXR
Citius Pharmaceuticals Inc
1.15 21.95M 0 -39.14M -28.20M -5.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-30 Hochstufung D. Boral Capital Hold → Buy
2021-11-30 Eingeleitet Maxim Group Buy

Citius Pharmaceuticals Inc Aktie (CTXR) Neueste Nachrichten

pulisher
Sep 03, 2025

Will Citius Pharmaceuticals Inc. see short term momentumInsider Buying & Weekly Watchlist for Consistent Profits - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Analyzing net buyer seller activity in Citius Pharmaceuticals Inc.July 2025 Opening Moves & Weekly Momentum Stock Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Citius Pharmaceuticals Inc. stock trend outlook and recovery pathExit Point & AI Driven Price Predictions - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can volume confirm reversal in Citius Pharmaceuticals Inc.Market Performance Report & Capital Protection Trading Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Volume spikes in Citius Pharmaceuticals Inc. stock – what they meanJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Citius Pharmaceuticals Inc. stock recover after recent dropGap Down & Comprehensive Market Scan Insights - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart based analysis of Citius Pharmaceuticals Inc. trendsEarnings Recap Report & Low Drawdown Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using economic indicators to assess Citius Pharmaceuticals Inc. potential - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

What is Citius Pharmaceuticals Inc. s debt to equity ratioJuly 2025 Intraday Action & Weekly High Return Stock Forecasts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Citius Pharmaceuticals Inc. part of any major indexEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Order flow analysis tools used on Citius Pharmaceuticals Inc.Global Markets & Expert Curated Trade Setup Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Citius Pharmaceuticals Inc. showing insider buyingMarket Growth Report & Consistent Growth Stock Picks - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Citius Pharmaceuticals Inc. stock trend forecastEarnings Beat & Weekly High Potential Stock Alerts - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

What data driven models say about Citius Pharmaceuticals Inc.’s futurePrice Action & Stepwise Entry and Exit Trade Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Will Citius Pharmaceuticals Inc. outperform the market2025 Price Momentum & Advanced Technical Signal Analysis - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Citius Pharmaceuticals Soars 10.71% on Strategic Initiatives - AInvest

Sep 01, 2025
pulisher
Sep 01, 2025

Citius Pharmaceuticals (CTXR) Soars 10.71% on Market Momentum - AInvest

Sep 01, 2025
pulisher
Aug 31, 2025

Does Citius Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 Setups & Safe Capital Allocation Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Citius Pharmaceuticals Inc. stock trendline breakdownGold Moves & Free Safe Entry Trade Signal Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Citius Pharmaceuticals Inc. trending in predictive chart modelsQuarterly Portfolio Report & Free Community Supported Trade Ideas - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Published on: 2025-08-30 20:04:43 - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Using R and stats models for Citius Pharmaceuticals Inc. forecastingSwing Trade & Stock Market Timing Techniques - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

RSI Crosses Above 30 for Citius Pharmaceuticals Inc. — Reversal in SightJuly 2025 EndofMonth & Risk Adjusted Buy/Sell Alerts - beatles.ru

Aug 30, 2025
pulisher
Aug 29, 2025

What is Citius Pharmaceuticals Inc.’s valuation compared to sector2025 Big Picture & High Accuracy Swing Entry Alerts - sundaytimes.kr

Aug 29, 2025
pulisher
Aug 29, 2025

Why Citius Pharmaceuticals Inc. is moving todayJuly 2025 Decliners & Consistent Growth Equity Picks - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

How to track smart money flows in Citius Pharmaceuticals Inc.2025 Historical Comparison & Real-Time Stock Movement Alerts - Newser

Aug 29, 2025

Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):